Literature DB >> 308998

alpha-difluoromethyl DOPA, a new enzyme-activated irreversible inhibitor of aromatic L-amino acid decarboxylase.

M G Palfreyman, C Danzin, P Bey, M J Jung, G Ribereau-Gayon, M Aubry, J P Vevert, A Sjoerdsma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 308998     DOI： 10.1111/j.1471-4159.1978.tb00129.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN： 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  4 in total

1.  Metoclopramide antagonism of 5-hydroxytryptophan-induced "wet-dog" shake behaviour in the rat.

Authors:  J R Fozard; M G Palfreyman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-06       Impact factor: 3.000

2.  Monamine-depleting properties of a new and very potent enzyme-activated irreversible inhibitor of aromatic aminoacid decarboxylase: alpha-monofluoromethyldopa [proceedings].

Authors:  M J Jung; M G Palfreyman; G Ribereau-Gayon; J Wagner; M Zraïka
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

3.  Further studies on the inhibition of monoamine synthesis by monofluoromethyldopa.

Authors:  P Bey; M J Jung; J Koch-Weser; M G Palfreyman; A Sjoerdsma; J Wagner; M Zraïka
Journal:  Br J Pharmacol       Date:  1980-12       Impact factor: 8.739

4.  The Parkinson's disease death rate: carbidopa and vitamin B6.

Authors:  Marty Hinz; Alvin Stein; Ted Cole
Journal:  Clin Pharmacol       Date:  2014-10-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.